Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-12-056063
Filing Date
2012-10-10
Accepted
2012-10-10 17:02:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 113092
  Complete submission text file 0000000000-12-056063.txt   157024
Mailing Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017
Business Address 425 METRO PLACE NORTH SUITE 300 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filed for) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2835 In Vitro & In Vivo Diagnostic Substances